RISE: Reducing Cancer and HIV Stigma Through Empowerment

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07728370
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cervical Cancer Stigma
  • HIV

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Neutral Video — BEHAVIORAL
    Participants in the control group will watch neutral videos and describe objective, non-emotional objects/events
  • Storytelling — BEHAVIORAL
    The storytelling intervention group will watch the storytelling videos and then describe objective, non-emotional objects/events.
  • Self disclosure — BEHAVIORAL
    Participants will watch neutral videos and then talk/write about their cancer/HIV-related experiences to themselves.
  • Combination — BEHAVIORAL
    The combination group will watch the storytelling videos and then talk/write about their cancer/HIV-related experiences to themselves.
  • Video — BEHAVIORAL
    Participants (healthcare workers) will watch storytelling videos in a group setting, followed by a facilitated discussion and role-playing to enhance empathy and understanding.
  • Waitlist — BEHAVIORAL
    Participants will watch unrelated presentations in a group setting while on a waitlist. They will receive the intervention after completing the post-test.

Study Details

This multilevel randomized behavioral study evaluates participant- and provider-level stigma-reduction interventions in Zambia. Participant-level intervention: Women living with cervical cancer and HIV (WLC+H ) are randomized in a 2×2 factorial design of storytelling versus neutral videos and storytelling versus neutral disclosure interventions to assess effects on quality of life, anxiety, and depressive symptoms. Provider-level intervention: Healthcare workers are randomized to storytelling or neutral videos to assess changes in stigma and compassion. The study also evaluates participant -reported stigma and satisfaction with care before and after implementation of the provider intervention.

Key Dates

First listed
Jul 27, 2026
Start date
Sep 1, 2026
Status verified
Jun 2026
Primary completion
May 31, 2030
Completion
Aug 31, 2030

Study Design

Enrollment
440 participants (estimated)
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Patient control group - neutral videos
  • Experimental: Patient storytelling group
  • Experimental: Patient self-disclosure group
  • Experimental: Patient combination group - storytelling video and storytelling disclosure
  • Experimental: Provider Storytelling group
  • Experimental: Provider waitlist control group

Primary Outcome Measure

Quality of Life (Cancer) [ Time Frame: Baseline, immediately after the intervention, and 1-, 3-, 6-, and 12- month follow up ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT MD AndersonHoustonTexas77030
Qian Lu, MD, PHD
(713) 745-8324
Qian Lu, MD, PHD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By condition
By specialty

Related Studies